Reports

Sale

Global Orthobiologics Market Size, Share, Analysis, Forecast: By Product: Demineralized Bone Matrices (DBM), Viscosupplementation, Bone Morphogenetic Protein, Plasma-rich Protein, Bone Marrow Aspirate Concentrate, Allografts, Others; By Type; By Application; By End Use; Regional Analysis; Competitive Landscape; 2024-2032

Global Orthobiologics Market Outlook

The global orthobiologics market is expected to grow at a CAGR of 4.6% in the forecast period of 2024-2032 to attain USD 11.40 billion by 2032.

Global Orthobiologics Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Improving Healthcare Infrastructure to Aid the Market Growth of Orthobiologics

Region-wise, North America is expected to be the leading market for orthobiologics in the forecast period of 2024-2032. This could be attributed to the prevalence of prominent players who promote quality care and regularly update strategies for product development. Furthermore, reimbursement policies and fusion enhancement products, combined with robust healthcare industry, has been propelling the market forward. Meanwhile, the market for orthobiologics is expected to grow at an exponential rate in the Asia Pacific region in the forecast period. Increasing awareness, both among doctors and patients of the benefits of these products, rising disposable incomes, and improving healthcare standards help grow the regional market. Enhancement of the healthcare infrastructure in the forecast period is expected to provide growth opportunities in the forecast period. Also, growing competition among key players leading to increasing product launches is also driving the market for orthobiologics forward.

Orthobiologics: Market Segmentation

Orthobiologics are substances that orthopaedic surgeons use to help and catalyse healing. Healing of broken bones and injured muscles, tendons, and ligaments are few of the areas these are used in. Orthobiologics consist of substances that naturally occur in the human body.

Global Orthobiologics Market By Product

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

The market is segmented on the basis of product into:

Demineralized Bone Matrices (DBM)
Viscosupplementation
Bone Morphogenetic Protein
Plasma-rich Protein
Bone Marrow Aspirate Concentrate
Allografts
Others

The market is divided by type into:

Knee
Ankle
Hip
Wrist and shoulder
Spine
Others

The market is segregated on the basis of application into:

Osteoarthritis and Degenerative Arthritis
Spinal Fusion
Soft-Tissue Injuries
Fracture Recovery
Maxillofacial and Dental Applications
Others

On the basis of end use, the market is bifurcated into:

Hospitals, Orthopaedic Clinics, and Ambulatory Care Centres
Dental Clinics and Facilities
Research and Academic Institute
Others

The regional markets for the product include North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

Global Orthobiologics Market By Region

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Rising Geriatric Population to Aid the Market Growth of Orthobiologics

Hip and knee replacement is expected to have risen and is expected to rise significantly in the coming years, being one of the main drivers of orthobiologics. Rising geriatric population and increased awareness about orthobiologics are easing the growth of this market. Hospitals are the leading market segment in terms of end use. This is due to increasing adoption of new procedures and the rise of high end as well as affordable hospitals. High patient turnaround and frequent readmissions push the segment share of hospitals. The supportive infrastructure that helps ensure the accuracy and reliability of the procedure is also driving the market forward. Further, increased investment in research and development and advanced technological innovations by the major market players is expected to push the market growth in the forecast period as well.

Key Industry Players in the Global Orthobiologics Market

The report gives a detailed analysis of the following key players in the global orthobiologics market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:

Kuros Biosciences A.G.
Bioventus LLC
Smith & Nephew Plc
Johnson & Johnson Services, Inc.
Stryker Corporation
Others

The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis.

Key Highlights of the Report

REPORT FEATURES	DETAILS
Base Year	2023
Historical Period	2017-2023
Forecast Period	2024-2032
Scope of the Report	Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment: Product Type Application End Use Region
Breakup by Product	Demineralized Bone Matrices (DBM) Viscosupplementation Bone Morphogenetic Protein Plasma-rich Protein Bone Marrow Aspirate Concentrate Allografts Others
Breakup by Type	Knee Ankle Hip Wrist and shoulder Spine Others
Breakup by Application	Osteoarthritis and Degenerative Arthritis Spinal Fusion Soft-Tissue Injuries Fracture Recovery Maxillofacial and Dental Applications Others
Breakup by End Use	Hospitals, Orthopedic Clinics, and Ambulatory Care Centres Dental Clinics and Facilities Research and Academic Institute Others
Breakup by Region	North America United States of America Canada Europe United Kingdom Germany France Italy Others Asia Pacific China Japan India ASEAN Australia Others Latin America Brazil Argentina Mexico Others Middle East and Africa Saudi Arabia United Arab Emirates Nigeria South Africa Others
Market Dynamics	SWOT Analysis Porter's Five Forces Analysis Key Indicators for Demand Key Indicators for Price
Competitive Landscape	Market Structure Company Profiles Company Overview Product Portfolio Demographic Reach and Achievements Certifications
Companies Covered	Kuros Biosciences A.G. Bioventus LLC Smith & Nephew Plc Johnson & Johnson Services, Inc. Stryker Corporation Others
Report Price and Purchase Option	Explore our purchase options that are best suited to your resources and industry needs.
Delivery Format	Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.

*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.

1   Preface
2   Report Coverage – Key Segmentation and Scope
3   Report Description
   3.1   Market Definition and Outlook
   3.2   Properties and Applications
   3.3   Market Analysis
   3.4   Key Players
4   Key Assumptions
5   Executive Summary
   5.1   Overview
   5.2   Key Drivers
   5.3   Key Developments
   5.4   Competitive Structure
   5.5   Key Industrial Trends
6   Snapshot
   6.1   Global
   6.2   Regional
7 Opportunities and Challenges in the Market
8   Global Orthobiologics Market Analysis
   8.1   Key Industry Highlights
   8.2   Global Orthobiologics Historical Market (2018-2023)
   8.3   Global Orthobiologics Market Forecast (2024-2032)
   8.4   Global Orthobiologics Market by Product
       8.4.1   Demineralized Bone Matrices (DBM)
           8.4.1.1 Historical Trend (2018-2023)
           8.4.1.2 Forecast Trend (2024-2032)
       8.4.2   Viscosupplementation
           8.4.2.1 Historical Trend (2018-2023)
           8.4.2.2 Forecast Trend (2024-2032)
       8.4.3   Bone Morphogenetic Protein
           8.4.3.1 Historical Trend (2018-2023)
           8.4.3.2 Forecast Trend (2024-2032)
       8.4.4   Plasma-rich Protein
           8.4.4.1 Historical Trend (2018-2023)
           8.4.4.2 Forecast Trend (2024-2032)
       8.4.5   Bone Marrow Aspirate Concentrate
           8.4.5.1 Historical Trend (2018-2023)
           8.4.5.2 Forecast Trend (2024-2032)
       8.4.6   Allografts
           8.4.6.1 Historical Trend (2018-2023)
           8.4.6.2 Forecast Trend (2024-2032)
       8.4.7   Others
   8.5   Global Orthobiologics Market by Type
       8.5.1   Knee
           8.5.1.1 Historical Trend (2018-2023)
           8.5.1.2 Forecast Trend (2024-2032)
       8.5.2   Ankle
           8.5.2.1 Historical Trend (2018-2023)
           8.5.2.2 Forecast Trend (2024-2032)
       8.5.3   Hip
           8.5.3.1 Historical Trend (2018-2023)
           8.5.3.2 Forecast Trend (2024-2032)
       8.5.4   Wrist and shoulder
           8.5.4.1 Historical Trend (2018-2023)
           8.5.4.2 Forecast Trend (2024-2032)
       8.5.5   Spine
           8.5.5.1 Historical Trend (2018-2023)
           8.5.5.2 Forecast Trend (2024-2032)
       8.5.6   Others
   8.6   Global Orthobiologics Market by Application
       8.6.1   Osteoarthritis and Degenerative Arthritis
           8.6.1.1 Historical Trend (2018-2023)
           8.6.1.2 Forecast Trend (2024-2032)
       8.6.2   Spinal Fusion
           8.6.2.1 Historical Trend (2018-2023)
           8.6.2.2 Forecast Trend (2024-2032)
       8.6.3   Soft-Tissue Injuries
           8.6.3.1 Historical Trend (2018-2023)
           8.6.3.2 Forecast Trend (2024-2032)
       8.6.4   Fracture Recovery
           8.6.4.1 Historical Trend (2018-2023)
           8.6.4.2 Forecast Trend (2024-2032)
       8.6.5   Maxillofacial and Dental Applications
           8.6.5.1 Historical Trend (2018-2023)
           8.6.5.2 Forecast Trend (2024-2032)
       8.6.6   Others
   8.7   Global Orthobiologics Market by End Use
       8.7.1   Hospitals, Orthopedic Clinics, and Ambulatory Care Centres
           8.7.1.1 Historical Trend (2018-2023)
           8.7.1.2 Forecast Trend (2024-2032)
       8.7.2   Dental Clinics and Facilities
           8.7.2.1 Historical Trend (2018-2023)
           8.7.2.2 Forecast Trend (2024-2032)
       8.7.3   Research and Academic Institute
           8.7.3.1 Historical Trend (2018-2023)
           8.7.3.2 Forecast Trend (2024-2032)
       8.7.4   Others
   8.8   Global Orthobiologics Market by Region
        8.8.1   North America
       8.8.2   Europe
      8.8.3   Asia Pacific
        8.8.4   Latin America
       8.8.5   Middle East and Africa
9   Regional Analysis
   9.1   North America
       9.1.1   Historical Trend (2018-2023)
       9.1.2   Forecast Trend (2024-2032)
       9.1.3   Breakup by Country
           9.1.3.1   United States of America
           9.1.3.2   Canada
   9.2   Europe
       9.2.1   Historical Trend (2018-2023)
       9.2.2   Forecast Trend (2024-2032)
       9.2.3   Breakup by Country Kingdom
           9.2.3.1   United
           9.2.3.2   Germany
           9.2.3.3   France
           9.2.3.4   Italy
           9.2.3.5   Others
   9.3   Asia Pacific
       9.3.1   Historical Trend (2018-2023)
       9.3.2   Forecast Trend (2024-2032)
       9.3.3   Breakup by Country
           9.3.3.1   China
           9.3.3.2   Japan
           9.3.3.3   India
           9.3.3.4   ASEAN
           9.3.3.5   Australia
           9.3.3.6   Others
   9.4   Latin America
       9.4.1   Historical Trend (2018-2023)
       9.4.2   Forecast Trend (2024-2032)
       9.4.3   Breakup by Country
           9.4.3.1   Brazil
           9.4.3.2   Argentina
           9.4.3.3   Mexico
           9.4.3.4   Others
   9.5   Middle East and Africa
       9.5.1   Historical Trend (2018-2023)
       9.5.2   Forecast Trend (2024-2032)
       9.5.3   Breakup by Country
           9.5.3.1   Saudi Arabia
           9.5.3.2   United Arab Emirates
           9.5.3.3   Nigeria
           9.5.3.4   South Africa
           9.5.3.5   Others
10   Market Dynamics
   10.1   SWOT Analysis
       10.1.1   Strengths
       10.1.2   Weaknesses
       10.1.3   Opportunities
       10.1.4   Threats
   10.2   Porter’s Five Forces Analysis
       10.2.1   Supplier’s Power
       10.2.2   Buyer’s Power
       10.2.3   Threat of New Entrants
       10.2.4   Degree of Rivalry
       10.2.5   Threat of Substitutes
   10.3   Key Indicators for Demand
   10.4   Key Indicators for Price
11   Value Chain Analysis
12   Competitive Landscape
   12.1   Market Structure
   12.2   Company Profiles
       12.2.1   Kuros Biosciences A.G.
           12.2.1.1   Company Overview
           12.2.1.2   Product Portfolio
           12.2.1.3   Demographic Reach and Achievements
           12.2.1.4   Certifications
       12.2.2   Bioventus LLC
           12.2.2.1   Company Overview
           12.2.2.2   Product Portfolio
           12.2.2.3   Demographic Reach and Achievements
           12.2.2.4   Certifications
       12.2.3   Smith & Nephew Plc
           12.2.3.1   Company Overview
           12.2.3.2   Product Portfolio
           12.2.3.3   Demographic Reach and Achievements
           12.2.3.4   Certifications
       12.2.4   Johnson & Johnson Services, Inc.
           12.2.4.1   Company Overview
           12.2.4.2   Product Portfolio
           12.2.4.3   Demographic Reach and Achievements
           12.2.4.4   Certifications
       12.2.5   Stryker Corporation
           12.2.5.1   Company Overview
           12.2.5.2   Product Portfolio
           12.2.5.3   Demographic Reach and Achievements
           12.2.5.4   Certifications
       12.2.6   Others
13   Key Trends and Developments in the Market

List of Key Figures and Tables

1.   Global Orthobiologics Market: Key Industry Highlights, 2018 and 2032
2.   Global Orthobiologics Historical Market: Breakup by Product (USD Billion), 2018-2023
3.   Global Orthobiologics Market Forecast: Breakup by Product (USD Billion), 2024-2032
4.   Global Orthobiologics Historical Market: Breakup by Type (USD Billion), 2018-2023
5.   Global Orthobiologics Market Forecast: Breakup by Type (USD Billion), 2024-2032
6.   Global Orthobiologics Historical Market: Breakup by Application (USD Billion), 2018-2023
7.   Global Orthobiologics Market Forecast: Breakup by Application (USD Billion), 2024-2032
8.   Global Orthobiologics Historical Market: Breakup by End Use (USD Billion), 2018-2023
9.   Global Orthobiologics Market Forecast: Breakup by End Use (USD Billion), 2024-2032
10.   Global Orthobiologics Historical Market: Breakup by Region (USD Billion), 2018-2023
11.   Global Orthobiologics Market Forecast: Breakup by Region (USD Billion), 2024-2032
12.   North America Orthobiologics Historical Market: Breakup by Country (USD Billion), 2018-2023
13.   North America Orthobiologics Market Forecast: Breakup by Country (USD Billion), 2024-2032
14.   Europe Orthobiologics Historical Market: Breakup by Country (USD Billion), 2018-2023
15.   Europe Orthobiologics Market Forecast: Breakup by Country (USD Billion), 2024-2032
16.   Asia Pacific Orthobiologics Historical Market: Breakup by Country (USD Billion), 2018-2023
17.   Asia Pacific Orthobiologics Market Forecast: Breakup by Country (USD Billion), 2024-2032
18.   Latin America Orthobiologics Historical Market: Breakup by Country (USD Billion), 2018-2023
19.   Latin America Orthobiologics Market Forecast: Breakup by Country (USD Billion), 2024-2032
20.   Middle East and Africa Orthobiologics Historical Market: Breakup by Country (USD Billion), 2018-2023
21.   Middle East and Africa Orthobiologics Market Forecast: Breakup by Country (USD Billion), 2024-2032
22.   Global Orthobiologics Market Structure

Key Questions Answered in the Report

What is the growth rate of the global orthobiologics market?

The global orthobiologics market is projected to grow at a CAGR of 4.6% between 2024 and 2032.

What are the major industry drivers?

The major drivers of the market include the increased awareness, increasing adoption of new procedures, rise of high end and affordable hospitals, supportive infrastructure, increased investment in research and development and advanced technological innovations.

What are the key industry trends of the global orthobiologics market?

Rise in hip and knee replacement cases and rising geriatric population are the key industry trends propelling the market's growth.

What are the major regional markets of orthobiologics, according to the EMR report?

The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.

What are the different products in the orthobiologics market?

The market is segmented on the basis of product into demineralized bone matrices (DBM), Visco supplementation, bone morphogenetic protein, plasma-rich protein, bone marrow aspirate concentrate, and allografts, among others.

What is the market division based on type?

The market is divided by type into knee, ankle, hip, wrist and shoulder, and spine, among others.

What are the major applications of the market?

The major applications are osteoarthritis and degenerative arthritis, spinal fusion, soft-tissue injuries, fracture recovery, maxillofacial and dental applications, among others.

What is the end-use of the market?

The end-uses are hospitals, orthopedic clinics, and ambulatory care centres, dental clinics and facilities, research and academic institute, among others.

Who are the key industry players, according to the report?

The major players in the industry are Kuros Biosciences A.G., Bioventus LLC, Smith & Nephew Plc, Johnson & Johnson Services, Inc., and Stryker Corporation, among others.

Analyst Review

The global orthobiologics market was driven by the rise in hip and knee replacement cases in the historical period. Aided by increasing adoption of new procedures and rising geriatric population, the market is expected to witness further growth in the forecast period of 2024-2032, growing at a CAGR of 4.6%.

EMR's meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. The market is segmented on the basis of product into demineralized bone matrices (DBM), Visco supplementation, bone morphogenetic protein, plasma-rich protein, bone marrow aspirate concentrate, and allografts, among others. The market is divided by type into knee, ankle, hip, wrist and shoulder, and spine, among others. The major applications are osteoarthritis and degenerative arthritis, spinal fusion, soft-tissue injuries, fracture recovery, maxillofacial and dental applications, among others. The end-uses are hospitals, orthopedic clinics, and ambulatory care centres, dental clinics and facilities, research and academic institute, among others. The major regional markets for orthobiologics are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. The major players in the industry are Kuros Biosciences A.G., Bioventus LLC, Smith & Nephew Plc, Johnson & Johnson Services, Inc., and Stryker Corporation, among others.

EMR's research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable and help them remain ahead of their competition.

Request Sample

Purchase Full Report

Mini Report

$ ~~2969~~ $2699

Selected Sections, One User
Printing Not Allowed
Email Delivery in PDF
~~Free Limited Customisation~~
~~Post Sales Analyst Support~~
~~50% Discount on Next Update~~

Buy Now

Single User License

$ ~~5499~~ $4999

All Sections, One User
One Print Allowed
Email Delivery in PDF
~~Free Limited Customisation~~
~~Post Sales Analyst Support~~
~~50% Discount on Next Update~~

Buy Now

Five User License

$ ~~6599~~ $5999

All Sections, Five Users
Five Prints Allowed
Email Delivery in PDF
Free Limited Customisation
Post Sales Analyst Support
~~50% Discount on Next Update~~

Buy Now

Corporate License

$ ~~7699~~ $6999

All Sections, Unlimited Users
Unlimited Prints Allowed
Email Delivery in PDF + Excel
Free Limited Customisation
Post Sales Analyst Support
50% Discount on Next Update

Buy Now

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation

Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

NEWSLETTER